Phosphoglycerate Mutase 1 Promotes Cell Proliferation and Neuroblast Differentiation in the Dentate Gyrus by Facilitating the Phosphorylation of cAMP Response Element-Binding Protein.
Dentate gyrus
Neurogenesis
Novel object recognition
Phosphoglycerate mutase 1
Journal
Neurochemical research
ISSN: 1573-6903
Titre abrégé: Neurochem Res
Pays: United States
ID NLM: 7613461
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
20
08
2018
accepted:
08
11
2018
revised:
02
11
2018
pubmed:
22
11
2018
medline:
8
5
2019
entrez:
22
11
2018
Statut:
ppublish
Résumé
In a previous study, we observed a significant increase in phosphoglycerate mutase 1 (PGAM1) levels after pyridoxine treatment. In the present study, we investigated the effects of PGAM1 on novel object recognition, cell proliferation, and neuroblast differentiation in the dentate gyrus. We generated a Tat-PGAM1 fusion protein to cross the blood-brain barrier and neuronal plasma membrane. We administered the Tat peptide, control-PGAM1, or Tat-PGAM1 fusion protein to 8-week-old mice once a day for 3 weeks and tested novel object recognition memory. The mice were then euthanized to conduct western blot analysis for polyhistidine expression and immunohistochemical analysis for Ki67, doublecortin, and phosphorylated cAMP response element-binding protein. Mice treated with Tat peptide showed similar exploration times for familiar and new objects and the discrimination index was significantly lower in this group than in the control group. Tat-PGAM1 moderately increased the exploration time of new objects when compared to familiar objects, while the discrimination index was significantly higher in the Tat-PGAM1-treated group, but not in the control-PGAM1-treated group, when compared with the control group. Higher PGAM1 protein expression was observed in the hippocampus of Tat-PGAM1-treated mice when compared with the hippocampi of control, Tat peptide-, and control-PGAM1-treated mice, using western blot analysis. In addition, the numbers of proliferating cells and differentiated neuroblasts were significantly lower in the Tat peptide-treated group than in the control group. In contrast, the numbers of proliferating cells and differentiated neuroblasts in the dentate gyrus were higher in the Tat-PGAM1-treated group than in the control group. Administration of Tat-PGAM1 significantly facilitated the phosphorylation of cAMP response element-binding protein in the dentate gyrus. Administration of control-PGAM1 did not show any significant effects on novel object recognition, cell proliferation, and neuroblast differentiation in the dentate gyrus. These results suggest that PGAM1 plays a role in cell proliferation and neuroblast differentiation in the dentate gyrus via the phosphorylation of cAMP response element-binding protein in the hippocampus.
Identifiants
pubmed: 30460638
doi: 10.1007/s11064-018-2678-5
pii: 10.1007/s11064-018-2678-5
doi:
Substances chimiques
Cyclic AMP Response Element-Binding Protein
0
Phosphoglycerate Mutase
EC 5.4.2.11
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
323-332Subventions
Organisme : Ministry of Education
ID : NRF-2016R1A2B4009156
Organisme : Ministry of Education
ID : NRF-2018R1A2B6001941
Références
Sci Am. 1999 May;280(5):48-53
pubmed: 10231988
Br J Cancer. 2000 Jan;82(1):20-7
pubmed: 10638961
FEBS Lett. 2000 Nov 24;485(2-3):163-7
pubmed: 11094160
Int J Cancer. 2001 Dec 1;94(5):662-8
pubmed: 11745460
Neuron. 2002 Apr 25;34(3):371-85
pubmed: 11988169
Neuron. 2002 Jun 13;34(6):999-1010
pubmed: 12086646
Carcinogenesis. 2004 Jun;25(6):865-71
pubmed: 14764456
Mol Psychiatry. 2004 Jul;9(7):684-97, 643
pubmed: 15098003
Free Radic Biol Med. 2004 Nov 15;37(10):1656-69
pubmed: 15477017
Proteomics. 2006 Jan;6(2):547-58
pubmed: 16342241
Electrophoresis. 2006 Apr;27(7):1417-23
pubmed: 16568407
Nat Neurosci. 2007 Mar;10(3):355-62
pubmed: 17277773
PLoS One. 2008 Apr 09;3(4):e1959
pubmed: 18509506
Microvasc Res. 2008 Aug;76(2):89-93
pubmed: 18533197
Expert Opin Investig Drugs. 2008 Oct;17(10):1533-45
pubmed: 18808312
J Proteome Res. 2009 Nov;8(11):4916-33
pubmed: 19739612
Am J Infect Dis. 2009 Jul 1;5(3):231-258
pubmed: 20352020
Mol Cancer. 2010 Apr 19;9:81
pubmed: 20403181
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Neurochem Res. 2011 May;36(5):713-21
pubmed: 21207138
Curr Opin Neurol. 2011 Jun;24(3):275-83
pubmed: 21467932
BMC Res Notes. 2012 Mar 15;5:146
pubmed: 22420779
J Neurosci Res. 2012 Aug;90(8):1615-25
pubmed: 22431394
J Neurosurg. 2013 Apr;118(4):846-53
pubmed: 23082878
Cancer Cell. 2012 Nov 13;22(5):585-600
pubmed: 23153533
Ann Neurol. 2012 Nov;72(5):648-72
pubmed: 23280789
J Proteomics. 2013 Feb 21;79:277-98
pubmed: 23313218
Learn Mem. 2013 Nov 19;20(12):710-29
pubmed: 24255101
J Neurochem. 2014 Jun;129(6):1002-12
pubmed: 24548049
Cell Mol Life Sci. 2014 Nov;71(22):4387-92
pubmed: 25134912
Ann Neurosci. 2013 Apr;20(2):67-70
pubmed: 25206016
J Proteomics. 2015 Jan 15;113:127-42
pubmed: 25286751
Adv Enzymol Relat Areas Mol Biol. 1989;62:227-313
pubmed: 2543188
J Cell Mol Med. 2015 Jun;19(6):1333-45
pubmed: 25781353
Behav Brain Funct. 2015 Feb 07;11:3
pubmed: 25880773
Cell Stem Cell. 2015 Oct 1;17(4):385-95
pubmed: 26431181
J Neurosci. 2015 Nov 4;35(44):14727-39
pubmed: 26538645
Lab Anim Res. 2016 Mar;32(1):1-7
pubmed: 27051437
Oncol Rep. 2016 Oct;36(4):2236-44
pubmed: 27572934
Neural Regen Res. 2016 Aug;11(8):1254-9
pubmed: 27651772
J Neurosci. 2016 Nov 2;36(44):11362-11373
pubmed: 27807176
Oncogene. 2017 May 18;36(20):2900-2909
pubmed: 27991922
Oncotarget. 2017 Feb 14;8(7):10773-10774
pubmed: 28121622
Cell. 1988 Dec 23;55(6):1179-88
pubmed: 2849509
Cell. 1988 Dec 23;55(6):1189-93
pubmed: 2849510
Mol Med Rep. 2017 Sep;16(3):3427-3432
pubmed: 28713906
Biochim Biophys Acta Gen Subj. 2017 Dec;1861(12):3142-3153
pubmed: 28935605
Acta Neuropathol. 2018 Mar;135(3):311-336
pubmed: 29411111
EMBO J. 2018 May 2;37(9):
pubmed: 29615453
Oncol Lett. 2018 Jun;15(6):8935-8940
pubmed: 29805628
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051